Who We Are
About AIC
Arthritis Innovation Corporation is a private, clinical-stage pharmaceutical company focused on improving recovery outcomes for patients undergoing
total knee replacement.
Our Mission
Science Driven by Unmet Needs.
Every year, more than 1 million total knee replacement surgeries are conducted in North America. While the surgery is highly effective, many patients continue to experience pain, inflammation, and delayed functional recovery that can limit their return to normal life.
Our mission is to redefine post-operative recovery by targeting the underlying inflammation that delays healing, enabling patients to recover faster, move better, and return sooner to the activities they love — because recovery is more than just pain management.
Proven Track Record for Innovation
Leadership
Our executive leadership team brings deep experience in orthopedics, financing, start-up pharmaceutical and medical device development, clinical affairs and and novel regulatory pathways, and CMC.
Wayne Marshall, MD, PhD
CEO
Matthew Shive, PhD
Chief Scientific Officer
Glenys Foster Roberts, PhD
VP Quality and Development
Learn About F14
Explore the science behind our First-in-Class lead product and the clinical evidence supporting its development.
About F14